{
    "Trade/Device Name(s)": [
        "Primus A1care Assay",
        "TRIstat Instrument",
        "TRIstatM Instrument",
        "Primus TRIstat Instrument"
    ],
    "Submitter Information": "Primus Corporation dba Primus Diagnostics",
    "510(k) Number": "K062658",
    "Predicate Device Reference 510(k) Number(s)": [
        "K891235"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JJE"
    ],
    "Summary Letter Date": "November 26, 2007",
    "Summary Letter Received Date": "October 29, 2007",
    "Submission Date": "October 26, 2007",
    "Regulation Number(s)": [
        "21CFR864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glycated hemoglobin (HbA1c)"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "TRIstat Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Boronate affinity assay",
        "Optical fluorescence quenching",
        "Two-phase optical assay"
    ],
    "Methodologies": [
        "Chromatographic separation",
        "Fluorescence measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for Primus TRIstat Instrument and A1care Assay for rapid measurement of percent glycated hemoglobin (HbA1c) using boronate affinity and fluorescence quenching.",
    "Indications for Use Summary": "Rapid in vitro diagnostic test to measure percent glycated hemoglobin (HbA1c) in human blood from finger stick or venous samples for clinical laboratory and point-of-care use to monitor long-term glucose control in individuals with diabetes mellitus.",
    "fda_folder": "Hematology"
}